According to an announcement from the Hong Kong Stock Exchange, Huajian Medical Development, a Hong Kong-listed Ethereum treasury company, announced it has acquired a 20.31% stake in Guofu Quantum for approximately HK$3.142 billion to advance its RWA exchange strategy. The transaction will be satisfied through the allotment and issuance of consideration shares at an issue price of HK$9.69 per share. Following the acquisition, Huajian Medical will become Guofu Quantum's majority shareholder and will be included in its financial statements using the equity method. This acquisition is part of Huajian Medical's advancement of its RWA (Real World Asset) exchange strategy, building a closed-loop ecosystem from the asset side to the transaction side, and will also contribute to its presence in the stablecoin market.

In August this year, Huajian Medical announced the official launch of a global enhanced Ethereum treasury strategy with a downside protection mechanism, and used Ethereum as its core reserve asset.